Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US6037325A · kind A · utility
9Cited by
8References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 30, 1998 |
| Grant date | Mar 14, 2000 |
| Priority date | — |
| Expiry date | Apr 30, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to certain substituted oxadiazole, thiadiazole and triazole peptoids which are useful as inhibitors of serine proteases including human neutrophil elastase, equivalently known as human leukocyte elastase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.